TVTX
Travere Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$62.76
−3.06%Forward multiples
Based on analyst estimates
- P/E forward
- 32.00x
- P/E 2026E
- —
- P/E 2027E
- 19.83x
- P/E 2028E
- 13.88x
- P/S forward
- 6.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 241.25x
- Price / sales
- 10.00x
- Price / cash flow
- 63.82x
Enterprise value
- Enterprise value
- $6.0B
- EV / sales
- 10.22x
- EV / EBITDA
- 3914.22x
- EV / EBIT
- -149.38x
- Market cap
- $5.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026